Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer therapy: new concepts on active immunization.

M Zöller1, S Matzku

  • 1Department of Tumor Progression and Immune Defense, German Cancer Research Center, Heidelberg. m.zoeller@dkfz-heidelberg.de

Immunobiology
|October 26, 1999
PubMed
Summary

Identifying immunogenic tumor antigens could enable new cancer vaccines. This approach bypasses tumor cells' poor antigen presentation, potentially activating a robust immune response to fight cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.

Journal of critical care·2020
Same author

Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.

Thrombosis research·2020
Same author

[Coronavirus disease 2019 : More safety through compact facts and recommendantions for action].

Der Anaesthesist·2020
Same author

[Is the discipline associated with self-confidence in handling rational antibiotic prescription? : Results from the MR2 study in German hospitals].

Der Anaesthesist·2020
Same author

Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant <i>Acinetobacter baumannii -</i> A case report.

Respiratory medicine case reports·2019
Same author

Current clinical use of intravenous fosfomycin in ICU patients in two European countries.

Infection·2019

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Tumors express molecules targeted by immunotherapy.
  • Tumor cells often fail at antigen presentation, hindering immune response.
  • Conventional antigen-presenting cells can process tumor antigens.

Purpose of the Study:

  • To explore the potential of targeting tumor antigens for cancer vaccination.
  • To overcome the limitations of tumor cell antigen presentation.
  • To develop novel immunotherapeutic strategies against cancer.

Main Methods:

  • Identification of immunogenic tumor-associated antigens.
  • Investigating antigen processing by antigen-presenting cells.

Main Results:

  • Established the principle of using antigen-presenting cells for tumor antigen processing.
  • Highlighted the potential for developing cancer vaccines based on tumor antigens.

Conclusions:

  • Identifying immunogenic tumor antigens is crucial for effective cancer vaccines.
  • This strategy offers a promising new avenue for cancer treatment.
  • Cancer vaccines could become a significant addition to existing cancer therapies.

Related Experiment Videos